Arginine methylation controls growth regulation by E2F-1

EMBO Journal

Volumn 31, Issue 7, 2012, Pages 1785-1797

  Cho, Er Chieh ^a   Zheng, Shunsheng ^a   Munro, Shonagh ^a   Liu, Geng ^a   Carr, Simon M ^a   Moehlenbrink, Jutta ^a   Lu, Yi Chien ^a   Stimson, Lindsay ^a   Khan, Omar ^a   Konietzny, Rebecca ^b   McGouran, Joanna ^a   Coutts, Amanda S ^b   Kessler, Benedikt ^a   Kerr, David J ^a   Thangue, Nicholas B La ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Arginine methylation; cancer; E2F 1; growth control

Indexed keywords

ARGININE; DNA; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 5; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH RATE; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MOTIF; PROTEIN STABILITY; TUMOR BIOPSY; TUMOR CELL;

APOPTOSIS; ARGININE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; METHYLATION; PROTEIN METHYLTRANSFERASES; PROTEIN STABILITY;

EID: 84862812370     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.17     Document Type: Article

References (43)

1. Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB, Diehl JA (2010) Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 18: 329-340
2. Bandara LR, La Thangue NB (1991) Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351: 494-497 (Pubitemid 21896628)
3. Batycka M, Inglis NF, Cook K, Adam A, Fraser-Pitt D, Smith DG, Main L, Lubben A, Kessler BM (2006) Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. Rapid Commun Mass Spectrom 20: 2074-2080 (Pubitemid 44049032)
4. Bedford MT, Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33: 1-13
5. Bedford MT, Richard S (2005) Arginine methylation an emerging regulator of protein function. Mol Cell 18: 263-272 (Pubitemid 41350532)
6. Blattner C, Sparks A, Lane D (1999) Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol Cell Biol 19: 3704-3713 (Pubitemid 29193830)
7. Branscombe TL, Frankel A, Lee JH, Cook JR, Yang Z, Pestka S, Clarke S (2001) PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem 276: 32971-32976
8. Evangelou K, Kotsinas A, Mariolis-Sapsakos T, Giannopoulos A, Tsantoulis PK, Constantinides C, Troupis TG, Salmas M, Kyroudis A, Kittas C, Gorgoulis VG (2008) E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol 61: 601-605 (Pubitemid 351678211)
9. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561 (Pubitemid 26157193)
10. Fischer R, Trudgian D, Wright C, Thomas G, Bradbury L, Brown M, Bowness P, Kessler B (2011) Discovery of candidate serum proteomic and metabolomic biomarkers in Ankylosing Spondylitis. Mol Cell Proteomics, (advance online publication, 13 October 2011)
11. Frolov MV, Dyson NJ (2004) Molecular mechanisms of E2Fdependent activation and pRB-mediated repression. J Cell Sci 117: 2173-2181 (Pubitemid 38807486)
12. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB (1993) A new component of the transcription factor DRTF1/E2F. Nature 362: 83-87 (Pubitemid 23087297)
13. Hofferer M, Wirbelauer C, Humar B, KrekW(1999) Increased levels of E2F-1-dependent DNA binding activity after UV-or y-irradiation. Nucl Acids Res 27: 491-495 (Pubitemid 29210013)
14. Iaquinta PJ, Lees JA (2007) Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657 (Pubitemid 350216426)
15. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin Jr WG (2000) Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645-648
16. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461: 1071-1078
17. Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, La Thangue NB (2008) Arginine methylation regulates the p53 response. Nat Cell Biol 10: 1431-1439
18. Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A (2010) Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J 29: 1105-1115
19. Kwon MJ, Nam ES, Cho SJ, Park HR, Shin HS, Park JH, Park CH, Lee WJ (2010) E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma. Ann Surg Oncol 17: 564-571
20. Lee J, Park CK, Park JO, Lim T, Park YS, Lim HY, Lee I, Sohn TS, Noh JH, Heo JS, Kim S, Lim do H, Kim KM, Kang WK (2008) Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res 14: 82-88 (Pubitemid 351409260)
21. Lee TA, Farnham PJ (2000) Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation. Oncogene 19: 2257-2268 (Pubitemid 30307192)
22. Liu G, Warbrick E (2006) The p66 and p12 subunits of DNA polymerase delta are modified by ubiquitin and ubiquitin-like proteins. Biochem Biophys Res Commun 349: 360-366 (Pubitemid 44331800)
23. Meister G, Eggert C, Buhler D, Brahms H, Kambach C, Fischer U (2001) Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 11: 1990-1994 (Pubitemid 33146428)
24. Midgley RS, McConkey CC, Johnstone EC, Dunn JA, Smith JL, Grumett SA, Julier P, Iveson C, Yanagisawa Y, Warren B, Langman MJ, Kerr DJ (2010) Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J Clin Oncol 28: 4575-4580
25. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S (2004) Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 24: 9630-9645 (Pubitemid 39391698)
26. Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, Gulino A, Levrero M (2003) Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 5: 552-558 (Pubitemid 36781090)
27. Polager S, Ginsberg D (2008) E2F-at the crossroads of life and death. Trends Cell Biol 18: 528-535
28. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256 (Pubitemid 34075816)
29. Rho J, Choi S, Seong YR, Cho WK, Kim SH, Im DS (2001) Prmt5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family. J Biol Chem 276: 11393-11401 (Pubitemid 38089332)
30. Rodicker F, Stiewe T, Zimmermann S, Putzer BM (2001) Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction. Cancer Res 61: 7052-7055 (Pubitemid 32946495)
31. Stanelle J, Putzer BM (2006) E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol Med 12: 177-185
32. Stevens C, La Thangue NB (2003) E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412: 157-169 (Pubitemid 36344139)
33. Stevens C, La Thangue NB (2004) The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 3: 1071-1079 (Pubitemid 38997950)
34. Stevens C, Smith L, La Thangue NB (2003) Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 5: 401-409 (Pubitemid 36592262)
35. Taylor GK, Goodlett DR (2005) Rules governing protein identification by mass spectrometry. Rapid Commun Mass Spectrom 19: 3420 (Pubitemid 41691915)
36. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T (1998) Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2: 293-304 (Pubitemid 128379270)
37. van den Heuvel S, Dyson NJ (2008) Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9: 713-724
38. Wang L, Wang R, Herrup K (2007) E2F-1 Works as a cell cycle suppressor in mature neurons. J Neuro Sci 27: 12555-12564 (Pubitemid 350127814)
39. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
40. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T (1998) Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+)mice. Nat Genet 18: 360-364 (Pubitemid 28158165)
41. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548 (Pubitemid 26157192)
42. Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS, La Thangue NB (2008) DNA-damage response control of E2F7 and E2F8. EMBO Rep 9: 252-259 (Pubitemid 351330990)
43. Zamanian M, La Thangue NB (1992) Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 11: 2603-2610